Report cover image

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Global Report 2026

Publisher The Business Research Company
Published Mar 18, 2026
Length 250 Pages
SKU # BRC21014927

Description

Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses good manufacturing practice (gmp) services for cell and gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for good manufacturing practice (gmp) services for cell and gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The good manufacturing practice (gmp) services for cell and gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope

Markets Covered:1) By Service Type: Process Development; Manufacturing; Analytical and Quality Control; Fill-Finish; Other Service Types

2) By Therapy Type: Cell Therapy; Gene Therapy; Combination Therapy

3) By Phase: Preclinical; Clinical; Commercial

4) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Other End-Users

Subsegments:

1) By Process Development: Vector Design Optimization; Cell Line Development; Upstream Process Optimization; Downstream Purification Development; Process Scale Up Studies

2) By Manufacturing: Clinical Trial Material Production; Commercial Scale Manufacturing; Viral Vector Manufacturing; Plasmid Production Services; Cell Therapy Manufacturing

3) By Analytical and Quality Control: Method Development And Validation; Potency And Efficacy Testing; Safety And Sterility Testing; Stability And Shelf Life Studies; Release Testing Services

4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Packaging And Labeling; Cold Chain Handling

5) By Other Service Types: Regulatory Support Services; Technology Transfer Services; Supply Chain Management; Storage And Distribution; Post Manufacturing Support

Companies Mentioned: Novartis AG; Boehringer Ingelheim BioXcellence GmbH; Batavia Biosciences B.V.; FUJIFILM Diosynth Biotechnologies; AGC Biologics Inc.; Lonza Group AG; WuXi AppTec Co. Ltd.; BioNTech Innovative Manufacturing Services; Charles River Laboratories International Inc.; Catalent Inc.; Samsung Biologics Co. Ltd.; Miltenyi Biotec GmbH; SK pharmteco Co. Ltd.; KBI Biopharma Inc.; Oxford Biomedica plc; OmniaBio Inc.; RoslinCT Ltd.; Pluri CDMO; SCTbio Inc.; Made Scientific Inc.; ENCell Co. Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Table of Contents

250 Pages
1. Executive Summary
1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market
2. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Characteristics
2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Attractiveness Scoring And Analysis
2.4.1. Overview of Market Attractiveness Framework
2.4.2. Quantitative Scoring Methodology
2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations
3. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Supply Chain Analysis
3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users
4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Trends And Strategies
4.1. Key Technologies & Future Trends
4.1.1 Biotechnology, Genomics & Precision Medicine
4.1.2 Industry 4.0 & Intelligent Manufacturing
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Sustainability, Climate Tech & Circular Economy
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Demand For Commercial-Scale Cell And Gene Therapy Manufacturing
4.2.2 Rising Adoption Of Viral Vector Production Services
4.2.3 Growing Focus On Gmp-Compliant Automation
4.2.4 Expansion Of Fill-Finish And Cold Chain Services
4.2.5 Enhanced Emphasis On Regulatory Compliance
5. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Cell Therapy Developers
5.4 Gene Therapy Developers
5.5 Contract Development And Manufacturing Organizations (Cdmos)
6. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Size, Comparisons And Growth Rate Analysis
7.3. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Segmentation
9.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Process Development, Manufacturing, Analytical and Quality Control, Fill-Finish, Other Service Types
9.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cell Therapy, Gene Therapy, Combination Therapy
9.3. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical, Clinical, Commercial
9.4. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End-Users
9.5. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Vector Design Optimization, Cell Line Development, Upstream Process Optimization, Downstream Purification Development, Process Scale Up Studies
9.6. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinical Trial Material Production, Commercial Scale Manufacturing, Viral Vector Manufacturing, Plasmid Production Services, Cell Therapy Manufacturing
9.7. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Analytical and Quality Control, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Method Development And Validation, Potency And Efficacy Testing, Safety And Sterility Testing, Stability And Shelf Life Studies, Release Testing Services
9.8. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Aseptic Filling Services, Vial And Syringe Filling, Lyophilization Services, Packaging And Labeling, Cold Chain Handling
9.9. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Regulatory Support Services, Technology Transfer Services, Supply Chain Management, Storage And Distribution, Post Manufacturing Support
10. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Regional And Country Analysis
10.1. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
11.1. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
12.1. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
13.1. India Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
14.1. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
15.1. Australia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
16.1. Indonesia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
17.1. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
18.1. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
19.1. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
20.1. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
21.1. UK Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
22.1. Germany Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
23.1. France Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
24.1. Italy Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
25.1. Spain Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
26.1. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
27.1. Russia Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
28.1. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
29.1. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
30.1. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
31.1. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
32.1. Brazil Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
33.1. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
34.1. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market, Segmentation By Service Type, Segmentation By Therapy Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Regulatory and Investment Landscape
36. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Landscape And Company Profiles
36.1. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Company Profiles
36.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Boehringer Ingelheim BioXcellence GmbH Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Batavia Biosciences B.V. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
36.3.5. AGC Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Other Major And Innovative Companies
Lonza Group AG, WuXi AppTec Co. Ltd., BioNTech Innovative Manufacturing Services, Charles River Laboratories International Inc., Catalent Inc., Samsung Biologics Co. Ltd., Miltenyi Biotec GmbH, SK pharmteco Co. Ltd., KBI Biopharma Inc., Oxford Biomedica plc, OmniaBio Inc., RoslinCT Ltd., Pluri CDMO, SCTbio Inc., Made Scientific Inc.
38. Global Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Competitive Benchmarking And Dashboard
39. Upcoming Startups in the Market
40. Key Mergers And Acquisitions In The Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market
41. Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market High Potential Countries, Segments and Strategies
41.1 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
41.2 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
41.3 Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market In 2030 - Growth Strategies
41.3.1 Market Trend Based Strategies
41.3.2 Competitor Strategies
42. Appendix
42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us